Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first and second-line treatment regimen: PROMETCO study

  • M. Koopman
  • , R. Garcia-Carbonero
  • , C. Pinto
  • , A. Mitroshkin
  • , G. Bodoky
  • , F. E. Marti Marti
  • , J. M. R. O'Connor
  • , S. John
  • , J. I. Sgouros
  • , H. F. Mansinho
  • , R. Greil
  • , P-J. Cuyle
  • , S. Plestina
  • , J. Ocvirk
  • , A. Sullivan
  • , E. Choucair
  • , B. Chevallier
  • , J-B. Bachet

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageEnglish
Pages (from-to)S36-S36
Number of pages1
JournalANNALS OF ONCOLOGY
Volume35
DOIs
Publication statusPublished - Jun 2024
EventGastrointestinal Cancers Congress of the European-Society-for-Medical-Oncology (ESMO) - Munich, Germany
Duration: 26 Jun 202429 Jun 2024

Cite this